Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Endoscopic Normalization and Transition of J-Pouch Phenotypes Over Time in Patients With Inflammatory Bowel Disease.
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit.
The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
Vedolizumab in the treatment of Crohn's disease.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Vedolizumab in the treatment of Crohn's disease.
Vedolizumab in the treatment of Crohn's disease. Expert Rev Gastroenterol Hepatol. 2016; 10(3):283-90.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Anti-Inflammatory Agents
Crohn Disease
Gastrointestinal Agents
Humans
Integrins
Remission Induction
Treatment Outcome
authors with profiles
David Rubin